From: Squamous cell carcinoma of the tonsillar remnant - clinical presentation and oncological outcome
Age at diagnosis (years) | Gender | Presenting symptoms | TNM stage | Management | Follow-up (months) | Outcome |
---|---|---|---|---|---|---|
43 | M | Neck Mass Unknown 1° | T1N3M0 | Excision Biopsy RND Radiotherapy | 120 | Alive |
67 | F | Neck Mass | T3N3M1 | Palliative care | 2 | Deceased |
57 | M | Sore throat Neck Mass | T4N2cM0 | KTP Bilateral MRND (type I+II) Radiotherapy Cisplatin Chemotherapy | Lost after 12 | Alive |
56 | F | Neck Mass Unknown 1° | TisN2aM0 | KTP MRND (type I) Radiotherapy | 72 | Alive |
74 | M | Neck Mass Unknown 1° | T1N1M0 | Radiotherapy | 84 | Alive |
47 | M | Neck Mass Tonsil Mass | T3N3M0 | KTP MRND (type I) Radiotherapy | 60 | Alive |
67 | F | Sore throat | T2N0M0 | Excision Biopsy Radiotherapy | 60 | Alive |
56 | M | Neck Mass Unknown 1° | T1N2bM0 | MRND Radiotherapy Cisplatin Chemotherapy | 68 | Alive |
50 | M | Neck Mass Unknown 1° | T2N2aM0 | MRND Radiotherapy Cisplatin Chemotherapy | 48 | Alive |
64 | M | Sore throat Neck Mass | T2N3M0 | Radiotherapy Cisplatin Chemotherapy Staged MRND | 24 | Alive |